International Stem Cell (OTCQB: ISCO), a California-based
biotechnology company developing novel stem cell-based therapies and biomedical
products, this morning announced that company board member and Chief Scientific
Officer Ruslan Semechkin, PhD, will present at the upcoming Rodman and Renshaw
17th Annual Global Investment Conference in New York.
Dr. Semechkin will provide a company overview and update on
development of clinical and research programs when he takes the floor
Wednesday, September 9, 2015, at 3 p.m. ET.
The company advises that you contact the conference
organizers if you have an interest in attending the conference or if you would
like to arrange a meeting with International Stem Cell’s management team.
International Stem Cell Corporation is focused on the
therapeutic applications of human parthenogenetic stem cells (hpSCs) and the
development and commercialization of cell-based research and cosmetic products.
The company’s core technology, parthenogenesis, results in the creation of pluripotent
human stem cells from unfertilized oocytes (eggs). hpSCs avoid ethical issues
associated with the use or destruction of viable human embryos. ISCO scientists
have created the first parthenogenic, homozygous stem cell line that can be a
source of therapeutic cells for hundreds of millions of individuals of
differing genders, ages and racial background with minimal immune rejection
after transplantation. hpSCs offer the potential to create the first true stem
cell bank, UniStemCell™.
International Stem Cell also produces and markets
specialized cells and growth media for therapeutic research worldwide through
its subsidiary Lifeline Cell Technology (www.lifelinecelltech.com), and stem
cell-based skin care products through its subsidiary Lifeline Skin Care
(www.lifelineskincare.com).
For more information visit www.internationalstemcell.com
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
